DE602006005831D1 - Verwendung von neboglamin bei der behandlung von abhängigkeit von toxischen substanzen - Google Patents
Verwendung von neboglamin bei der behandlung von abhängigkeit von toxischen substanzenInfo
- Publication number
- DE602006005831D1 DE602006005831D1 DE602006005831T DE602006005831T DE602006005831D1 DE 602006005831 D1 DE602006005831 D1 DE 602006005831D1 DE 602006005831 T DE602006005831 T DE 602006005831T DE 602006005831 T DE602006005831 T DE 602006005831T DE 602006005831 D1 DE602006005831 D1 DE 602006005831D1
- Authority
- DE
- Germany
- Prior art keywords
- neboglamine
- treatment
- dependence
- toxic substances
- toxicodependency
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- VCRGLZYPNNAVRP-JTQLQIEISA-N (4s)-4-amino-5-[(4,4-dimethylcyclohexyl)amino]-5-oxopentanoic acid Chemical compound CC1(C)CCC(NC(=O)[C@@H](N)CCC(O)=O)CC1 VCRGLZYPNNAVRP-JTQLQIEISA-N 0.000 title abstract 4
- 229950007573 neboglamine Drugs 0.000 title abstract 2
- 231100000614 poison Toxicity 0.000 title 1
- 239000003440 toxic substance Substances 0.000 title 1
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 240000004308 marijuana Species 0.000 abstract 2
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 abstract 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract 1
- 229940125717 barbiturate Drugs 0.000 abstract 1
- 229940049706 benzodiazepine Drugs 0.000 abstract 1
- 150000001557 benzodiazepines Chemical class 0.000 abstract 1
- 229960003920 cocaine Drugs 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 235000013922 glutamic acid Nutrition 0.000 abstract 1
- 239000004220 glutamic acid Substances 0.000 abstract 1
- 239000000380 hallucinogen Substances 0.000 abstract 1
- RHCSKNNOAZULRK-UHFFFAOYSA-N mescaline Chemical compound COC1=CC(CCN)=CC(OC)=C1OC RHCSKNNOAZULRK-UHFFFAOYSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229940127240 opiate Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229940125723 sedative agent Drugs 0.000 abstract 1
- 239000000932 sedative agent Substances 0.000 abstract 1
- 239000000021 stimulant Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Addiction (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000691A ITTO20050691A1 (it) | 2005-10-04 | 2005-10-04 | Uso di neboglamine nella terapia delle tossicodipendenze |
| PCT/IB2006/053603 WO2007039869A2 (en) | 2005-10-04 | 2006-10-03 | Use of neboglamine in the treatment of toxicodependency |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602006005831D1 true DE602006005831D1 (de) | 2009-04-30 |
Family
ID=37814217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602006005831T Active DE602006005831D1 (de) | 2005-10-04 | 2006-10-03 | Verwendung von neboglamin bei der behandlung von abhängigkeit von toxischen substanzen |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20100197962A1 (de) |
| EP (1) | EP1940376B1 (de) |
| JP (1) | JP2009510158A (de) |
| AT (1) | ATE425748T1 (de) |
| AU (1) | AU2006298393B2 (de) |
| CA (1) | CA2624449C (de) |
| DE (1) | DE602006005831D1 (de) |
| ES (1) | ES2323982T3 (de) |
| IT (1) | ITTO20050691A1 (de) |
| WO (1) | WO2007039869A2 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3031123C (en) | 2018-01-23 | 2023-11-07 | High Sierra Technologies, Inc. | Cannabis products modified by removing volatile organic compounds and adding volatile unsaturated hydrocarbons |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9024738D0 (en) * | 1990-11-14 | 1991-01-02 | Erba Carlo Spa | A new method of treatment of tumor necroisis factor(tnf)-related diseases |
| GB9109007D0 (en) * | 1991-04-26 | 1991-06-12 | Merck Sharp & Dohme | Therapeutic method |
| IT1264765B1 (it) * | 1993-03-10 | 1996-10-04 | Rotta Research Lab | Derivati dell'acido glutammico ed acido aspartico, procedimento per la loro preparazione e loro uso come farmaci potenzianti la |
| US5523323A (en) * | 1993-09-14 | 1996-06-04 | Maccecchini; Maria-Luisa | Use of partial agonists of the NMDA receptor to reduce opiate induced tolerance and dependence |
| ITTO20040343A1 (it) * | 2004-05-24 | 2004-08-24 | Rotta Res Lab Spa | Uso di neboglamine (cr2249) come neuropsicotico e neuroprotettivo |
-
2005
- 2005-10-04 IT IT000691A patent/ITTO20050691A1/it unknown
-
2006
- 2006-10-03 AT AT06809478T patent/ATE425748T1/de not_active IP Right Cessation
- 2006-10-03 AU AU2006298393A patent/AU2006298393B2/en not_active Ceased
- 2006-10-03 JP JP2008534130A patent/JP2009510158A/ja active Pending
- 2006-10-03 US US12/067,390 patent/US20100197962A1/en not_active Abandoned
- 2006-10-03 ES ES06809478T patent/ES2323982T3/es active Active
- 2006-10-03 CA CA2624449A patent/CA2624449C/en not_active Expired - Fee Related
- 2006-10-03 DE DE602006005831T patent/DE602006005831D1/de active Active
- 2006-10-03 WO PCT/IB2006/053603 patent/WO2007039869A2/en active Application Filing
- 2006-10-03 EP EP06809478A patent/EP1940376B1/de not_active Not-in-force
-
2011
- 2011-07-27 US US13/192,071 patent/US8258185B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2323982T3 (es) | 2009-07-28 |
| ITTO20050691A1 (it) | 2007-04-05 |
| EP1940376B1 (de) | 2009-03-18 |
| WO2007039869A2 (en) | 2007-04-12 |
| AU2006298393B2 (en) | 2011-04-14 |
| WO2007039869A3 (en) | 2007-07-05 |
| AU2006298393A1 (en) | 2007-04-12 |
| US20100197962A1 (en) | 2010-08-05 |
| ATE425748T1 (de) | 2009-04-15 |
| CA2624449C (en) | 2013-12-17 |
| US20110288173A1 (en) | 2011-11-24 |
| US8258185B2 (en) | 2012-09-04 |
| EP1940376A2 (de) | 2008-07-09 |
| JP2009510158A (ja) | 2009-03-12 |
| CA2624449A1 (en) | 2007-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2005090296A3 (en) | N-substituted benzene sulfonamides | |
| ATE484494T1 (de) | Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen | |
| BRPI0508051A (pt) | derivados de heteroarilaminopirazol utilizáveis para o tratamento de diabetes | |
| BR0315296A (pt) | Derivados do ciclohexanol espirocìclicos | |
| WO2006116148A3 (en) | (7-arlysubstituted 2, 3-dihydr0-1-benz0furan-2-yl) alkylamines in the treatment' of substance abuse | |
| BRPI0418099A (pt) | compostos, composição farmacêutica, e uso de um composto | |
| BRPI0619153A8 (pt) | derivados de 4-aminopirroltriazina substituída, e composição farmacêutica | |
| EA200700202A1 (ru) | Гетероарильные соединения в качестве бетамиметиков для лечения заболеваний дыхательных путей | |
| SE0201544D0 (sv) | Novel compounds and thier use | |
| EA200601837A1 (ru) | Бензоксазины для лечения заболеваний дыхательных путей | |
| BRPI0407662B8 (pt) | derivados do ácido 1-fenilalcanocarboxílico para o tratamento de doenças neurodegenerativas | |
| WO2007024651A3 (en) | Bridged n-bicyclic sulfonamido inhibitors of gamma secretase | |
| UY27993A1 (es) | Derivados de 4-pirrolidino-fenil-bencil eter | |
| WO2003087049A3 (de) | Arzneimittelkombinationen enthaltend heterocyclische verbindungen und ein neues anticholinergikum | |
| EA200701856A1 (ru) | Тетрагидропиридоазепин-8-оны и родственные соединения для лечения шизофрении | |
| EA200701615A1 (ru) | Новые лекарственные средства для лечения заболеваний дыхательных путей | |
| DE60202603D1 (de) | 8-(c-beta-d-glucopyranosyl)-7,3',4'-trihydroxyflavone, verfahren zur isolation aus pterocarpus marsupium und pharmazeutische zusammensetzung zur behandlung von diabetes | |
| DE602006002608D1 (de) | 4-phenyl-5-oxo-l,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit | |
| CL2004001068A1 (es) | Compuestos derivados de 2,3,4,5-tetrahidrobenzo[f][1,4]oxazepina; procedimientos de preparacion; composicion farmaceutica que los contiene y su uso en la elaboracion de un medicamento util para el tratamiento de la enfermedad de alzheimer. | |
| EA200900269A1 (ru) | Лекарственные комбинации для лечения заболеваний дыхательных путей | |
| DE602006005831D1 (de) | Verwendung von neboglamin bei der behandlung von abhängigkeit von toxischen substanzen | |
| DE602004020337D1 (de) | Anticholinergika enthaltende Arzneimittel zur Behandlung von Krankheiten der ableitenden Harnwege | |
| DE602005020618D1 (de) | Verwendung von neboglamine zur behandlung von schizophrenie | |
| ATE505193T1 (de) | Arzneimittelkombinationen zur behandlung von atemwegserkrankungen | |
| TH81375A (th) | สารประกอบใหม่ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |